跳至主要内容
临床试验/NCT07260929
NCT07260929已完成不适用

VR Goggles-Supported Virtual Reality Model in Midwifery Basic Clinical Skills Training: A Randomized Controlled Trial

University of Gaziantep1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
1
主要终点
Improvement in Basic Midwifery Clinical Skills Performance

研究概览

简要总结

This randomized controlled trial aims to evaluate the effectiveness of a virtual reality (VR)-based training model supported by VR goggles in improving basic clinical skills among midwifery students. Traditional skills training in midwifery education can be limited by time, instructor availability, and opportunities for repeated practice. VR technology offers an immersive, standardized, and repeatable learning environment that may enhance skill development and learner engagement.

In this study, midwifery students will be randomly assigned to either the VR training group or the traditional training group. Participants in the VR group will practice selected basic clinical skills using a VR goggle-supported simulation model, while the control group will receive standard skills laboratory training. Both groups will be evaluated through objective structured clinical examinations (OSCEs), self-confidence scales, and skill performance checklists.

The study aims to determine whether VR-enhanced training improves clinical skill acquisition, performance accuracy, and learner confidence compared with traditional methods. Findings from this research may help inform modern, technology-supported approaches to midwifery education.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Currently enrolled as an undergraduate midwifery student at Gaziantep University.
  • Registered in or scheduled to take the "Basic Clinical Skills" course during the study period.
  • Aged 18 years or older.
  • Able to provide informed consent and willing to participate throughout the study.
  • Has no previous formal training with virtual reality (VR) simulation related to midwifery clinical skills.
  • Able to use VR goggles safely (no known conditions that prevent VR use, such as severe motion sickness).

排除标准

  • A diagnosed visual, neurological, or vestibular disorder that may interfere with VR use (e.g., epilepsy, severe vertigo).
  • A history of severe motion sickness symptoms triggered by digital screens or VR environments.
  • Participated previously in a pilot version of the VR training module.
  • Currently taking a leave of absence or not actively attending coursework.

研究组 & 干预措施

Experimental (VR Goggle-Assisted VR Training)

Experimental

Participants in this arm will receive basic clinical skills training using a VR goggle-supported virtual reality model specifically designed for midwifery education. The VR module includes interactive simulations, step-by-step procedural guidance, and scenario-based skill practice. Training will be delivered individually under supervision and will cover essential midwifery clinical skills.

干预措施: VR Goggle-Assisted Simulation Training (Behavioral)

Active Comparator: Traditional Training

Active Comparator

Participants in this arm will receive traditional basic clinical skills training using standard educational methods such as demonstration, skills laboratory practice, and return demonstration. This training follows the current curriculum used in midwifery clinical skills education and does not include virtual reality components.

干预措施: Standard Clinical Skills Training (Behavioral)

结局指标

主要结局

Improvement in Basic Midwifery Clinical Skills Performance

时间窗: Baseline (pre-training) and immediately post-training (within 1 week after completion of the training program)

Performance in core midwifery clinical skills (e.g., abdominal examination, Leopold maneuvers, vital signs assessment, hand hygiene, perineal care, and communication skills) will be evaluated using a validated Objective Structured Clinical Examination (OSCE) checklist. Higher scores indicate better skill performance. Student satisfaction and self-confidence in learning will be evaluated using the "Student Satisfaction and Self-Confidence in Learning Scale," which consists of 13 items rated on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 13 (minimum) to 65 (maximum), and higher scores indicate greater satisfaction with the instructional experience and higher self-confidence in learning.

Improvement in Basic Midwifery Clinical Skills Performance

时间窗: Baseline (pre-training) and immediately post-training (within 1 week after completion of the training program)

Performance in core midwifery clinical skills (e.g., abdominal examination, Leopold maneuvers, vital signs assessment, hand hygiene, perineal care, and communication skills) will be evaluated using a validated Objective Structured Clinical Examination (OSCE) checklist. Higher scores indicate better skill performance. Student satisfaction and self-confidence in learning will be evaluated using the "Student Satisfaction and Self-Confidence in Learning Scale," which consists of 13 items rated on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 13 (minimum) to 65 (maximum), and higher scores indicate greater satisfaction with the instructional experience and higher self-confidence in learning.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ezgi Dirgar

Associate Professor

University of Gaziantep

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
A study to assess the efficacy and safety of Sodium Zirconium Cyclosilicate (SZC) for the Management of High Potassium in Patients with Symptomatic Heart Failure with Reduced Ejection Fraction and Receiving SpironolactoneHyperkalemia in Patients with Symptomatic Heart Failure.MedDRA version: 21.1Level: PTClassification code 10020646Term: HyperkalaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2020-003312-27-HUAstraZeneca AB400
招募中
1 期
A study to assess the efficacy and safety of Sodium Zirconium Cyclosilicate (SZC) for the Management of High Potassium in Patients with Symptomatic Heart Failure with Reduced Ejection Fraction and Receiving SpironolactoneHyperkalemia in Patients with Symptomatic Heart FailureMedDRA version: 21.1Level: PTClassification code 10020646Term: HyperkalaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2020-003312-27-ESAstraZeneca AB400
进行中(未招募)
不适用
Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kggenotype 1 chronic hepatitis C infection of high viral titer and baseline body weight greater than or equal to 85 kgMedDRA version: 8.1Level: LLTClassification code 10008912Term: Chronic hepatitis C
EUCTR2005-005507-41-HUF. Hoffmann-La Roche Ltd1,140
进行中(未招募)
不适用
Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kg - PROGRESSgenotype 1 chronic hepatitis C infection of high viral titer and baseline body weight greater than or equal to 85 kgMedDRA version: 8.1Level: LLTClassification code 10008912Term: Chronic hepatitis C
EUCTR2005-005507-41-NLF. Hoffmann-La Roche Ltd1,140
进行中(未招募)
1 期
Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kg - PROGRESS
EUCTR2005-005507-41-GBF. Hoffmann-La Roche Ltd1,140